Article Information
PubMed
Published By
History
- Received October 25, 2019
- Revision received April 21, 2020
- Accepted April 22, 2020
- Published online April 30, 2020.
Copyright & Usage
Copyright © 2020 Wilkie et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Crystal M. Wilkie,
- Jocelyn R. Barnes,
- Cherry-Lynn M. Benson,
- Kyle J. Brymer,
- Firoozeh Nafar and
- Matthew P. Parsons
- Division of Biomedical Sciences, Faculty of Medicine, Memorial University, St. John’s, Newfoundland A1B 3V6, Canada
- Correspondence should be addressed to Matthew P. Parsons at matthew.parsons{at}med.mun.ca.
Author contributions
Author contributions: C.M.W., J.R.B., and M.P.P. designed research; C.M.W., J.R.B., C.M.B., K.J.B., and F.N. performed research; C.M.W., J.R.B., C.M.B., and M.P.P. analyzed data; C.M.W., J.R.B., and M.P.P. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by funding from the following sources: a Natural Sciences and Engineering Research Council of Canada Discovery Grant; a Huntington Society of Canada Navigator Grant; and an Epilepsy NL Research Grant.
Funding
Huntington's Society of Canada
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
Epilepsy Newfoundland and Labrador
Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)
Other Version
- You are viewing the most recent version of this article.
- previous version (April 30, 2020).
Article usage
In this issue
Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment
